Nightstar files for $86M IPO to fund gene therapy trials – FierceBiotech
FierceBiotechNightstar files for $86M IPO to fund gene therapy trialsFierceBiotechNightstar Therapeutics has filed to raise up to $86 million in a Nasdaq IPO. The money will equip Nightstar to complete a phase 3 trial of its choroideremia gene therapy … Continue reading
